201 related articles for article (PubMed ID: 22052472)
21. Leptin-induced inflammation by activating IL-6 expression contributes to the fibrosis and hypertrophy of ligamentum flavum in lumbar spinal canal stenosis.
Sun C; Wang Z; Tian JW; Wang YH
Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29436483
[TBL] [Abstract][Full Text] [Related]
22. Hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis is associated with increased bFGF expression.
Honsawek S; Poonpukdee J; Chalermpanpipat C; Payungporn S; Limthongkul W; Yingsakmongkol W; Thanakit V; Parkpian V
Int Orthop; 2013 Jul; 37(7):1387-92. PubMed ID: 23519824
[TBL] [Abstract][Full Text] [Related]
23. Lumbar ligamentum flavum hypertrophy is due to accumulation of inflammation-related scar tissue.
Sairyo K; Biyani A; Goel VK; Leaman DW; Booth R; Thomas J; Ebraheim NA; Cowgill IA; Mohan SE
Spine (Phila Pa 1976); 2007 May; 32(11):E340-7. PubMed ID: 17495768
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of vascular endothelial growth factor is associated with hypertrophic ligamentum flavum in lumbar spinal canal stenosis.
Jirathanathornnukul N; Limthongkul W; Yingsakmongkol W; Singhatanadgige W; Parkpian V; Honsawek S
J Investig Med; 2016 Apr; 64(4):882-7. PubMed ID: 26956787
[TBL] [Abstract][Full Text] [Related]
25. Expression and function of FGF9 in the hypertrophied ligamentum flavum of lumbar spinal stenosis patients.
Habibi H; Suzuki A; Hayashi K; Salimi H; Terai H; Hori Y; Tamai K; Orita K; Ohyama S; Yabu A; Maruf MH; Nakamura H
Spine J; 2021 Jun; 21(6):1010-1020. PubMed ID: 33577925
[TBL] [Abstract][Full Text] [Related]
26. Relationship between Severity of Lumbar Spinal Stenosis and Ligamentum Flavum Hypertrophy and Serum Inflammatory Factors.
He N; Qi W; Zhao Y; Wang X
Comput Math Methods Med; 2022; 2022():8799240. PubMed ID: 36277021
[TBL] [Abstract][Full Text] [Related]
27. The correlation between imaging expression of P16 and S100 in hypertrophic ligamentum flavum.
Hu W; Liu Y; Kan S; Zhang T; Jiang Z; Zhu R
BMC Musculoskelet Disord; 2020 Jun; 21(1):359. PubMed ID: 32513152
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcome of lumbar spinal stenosis based on new classification according to hypertrophied ligamentum flavum.
Sakai Y; Ito S; Hida T; Ito K; Harada A; Watanabe K
J Orthop Sci; 2017 Jan; 22(1):27-33. PubMed ID: 27580526
[TBL] [Abstract][Full Text] [Related]
29. Hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis is associated with abnormal accumulation of specific lipids.
Yamada T; Horikawa M; Sato T; Kahyo T; Takanashi Y; Ushirozako H; Kurosu K; Al Mamun M; Mihara Y; Oe S; Arima H; Banno T; Yosida G; Hasegawa T; Yamato Y; Matsuyama Y; Setou M
Sci Rep; 2021 Dec; 11(1):23515. PubMed ID: 34873238
[TBL] [Abstract][Full Text] [Related]
30. Biglycan expression and its function in human ligamentum flavum.
Salimi H; Suzuki A; Habibi H; Orita K; Hori Y; Yabu A; Terai H; Tamai K; Nakamura H
Sci Rep; 2021 Mar; 11(1):4867. PubMed ID: 33649499
[TBL] [Abstract][Full Text] [Related]
31. Myofibroblasts are increased in the dorsal layer of the hypertrophic ligamentum flavum in lumbar spinal canal stenosis.
Hayashi F; Morimoto M; Higashino K; Goda Y; Sato N; Tezuka F; Yamashita K; Sairyo K
Spine J; 2022 Apr; 22(4):697-704. PubMed ID: 34775048
[TBL] [Abstract][Full Text] [Related]
32. Macrophage migration inhibitory factor takes part in the lumbar ligamentum flavum hypertrophy.
Lu QL; Zheng ZX; Ye YH; Lu JY; Zhong YQ; Sun C; Xiong CJ; Yang GX; Xu F
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35904178
[TBL] [Abstract][Full Text] [Related]
33. Hypertrophy of ligamentum flavum in lumbar spine stenosis is associated with increased miR-155 level.
Chen J; Liu Z; Zhong G; Qian L; Li Z; Qiao Z; Chen B; Wang H
Dis Markers; 2014; 2014():786543. PubMed ID: 24963214
[TBL] [Abstract][Full Text] [Related]
34. GSK-3β and β-Catenin Signaling Pathway is Involved in Myofibroblast Transition of Ligamentum Flavum in Lumbar Spinal Stenosis Patients.
Shin HK; Seo KJ; Lee JY; Jeon SR; Yune TY
Spine (Phila Pa 1976); 2023 Oct; 48(20):1472-1479. PubMed ID: 37417723
[TBL] [Abstract][Full Text] [Related]
35. Proteomic analysis of ligamentum flavum from patients with lumbar spinal stenosis.
Kamita M; Mori T; Sakai Y; Ito S; Gomi M; Miyamoto Y; Harada A; Niida S; Yamada T; Watanabe K; Ono M
Proteomics; 2015 May; 15(9):1622-30. PubMed ID: 25641790
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of lumbar stenosis and root pain resulting from simple hypertrophy of lumbar ligamentum flavum].
Liu LM; Song YM; Gong Q
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Jan; 17(1):50-1. PubMed ID: 12916310
[TBL] [Abstract][Full Text] [Related]
37. Decreased elastic fibers and increased proteoglycans in the ligamentum flavum of patients with lumbar spinal canal stenosis.
Yabe Y; Hagiwara Y; Tsuchiya M; Honda M; Hatori K; Sonofuchi K; Kanazawa K; Koide M; Sekiguchi T; Itaya N; Itoi E
J Orthop Res; 2016 Jul; 34(7):1241-7. PubMed ID: 26679090
[TBL] [Abstract][Full Text] [Related]
38. The role of vascularization on changes in ligamentum flavum mechanical properties and development of hypertrophy in patients with lumbar spinal stenosis.
Jezek J; Sepitka J; Daniel M; Kujal P; Blankova A; Waldauf P; Krbec M; Dousa P; Skala-Rosenbaum J; Samal F; Jirasek T
Spine J; 2020 Jul; 20(7):1125-1133. PubMed ID: 32179155
[TBL] [Abstract][Full Text] [Related]
39. Increased sorbitol levels in the hypertrophic ligamentum flavum of diabetic patients with lumbar spinal canal stenosis.
Luo J; Huang L; Chen Z; Zeng Z; Miyamoto T; Wu H; Zhang Z; Pan Z; Fujita N; Hikata T; Iwanami A; Tsuji T; Ishii K; Nakamura M; Matsumoto M; Watanabe K; Cao K
J Orthop Res; 2017 May; 35(5):1058-1066. PubMed ID: 27208686
[TBL] [Abstract][Full Text] [Related]
40. Hypertrophy of the ligament flavum in degenerative lumbar stenosis associated with the increased expression of fractalkine (CX3CL1)/CX3CR1 chemokine.
Oh IS; Suh DW; Ha KY
Connect Tissue Res; 2013; 54(6):380-5. PubMed ID: 24060055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
